Nausea is especially prominent, with diarrhea, vomiting, constipation, abdominal discomfort, and reflux also reported
Experts are now turning their attention toward helping GLP-1 patients maintain muscle while dropping fat, according to a pair of new studies presented at the American Diabetes Associations annual meeting in Chicago
Additionally, GLP-1-based treatments are being studied for their potential in managing obesity
Unlike traditional GLP-1 medications that activate a single hormone pathway, tirzepatide works by targeting two important metabolic hormones: Glucose-dependent insulinotropic polypeptide (GIP) Glucagon-like peptide-1 (GLP-1) These hormones play a role in: Appetite control Hunger signaling Blood sugar regulation Insulin production Energy utilization Metabolic function By activating both pathways, tirzepatide helps support a more comprehensive metabolic response than medications that target GLP-1 receptors alone
By stimulating insulin secretion and slowing gastric emptying, tirzepatide helps to keep blood sugar levels stable and reduces appetite